Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. FSPHX: which is better?

Bottom line

GNMX vs FSPHX: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and FSPHX (Health Care Portfolio) are both etfs.

Updated Nov 19, 2026

GNMX vs FSPHX side by side

GNMXFSPHX
TypeETFMutual fund
Fund familyCorgi Genomics & Precision MedicineFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.62%
Annual cost per $10k—$62
10-yr cost on $10k (prospectus)—$774
Max front loadNone—
12b-1 fee—0%
1-yr return—+14.4%
5-yr return (annualized)—+4.0%
10-yr return (annualized)—+9.0%
Best quarter—+22.2%
Worst quarter—−15.0%
Net assets (fund)—$5.8B
Number of holdings—152
Portfolio turnover—69%
Returns as of—Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and FSPHX share none of their top holdings.

GNMX top 10

    FSPHX top 10

    1. ELI LILLY and CO — 8.03%
    2. Danaher Corp — 6.89%
    3. JOHNSON and JOHNSON — 4.91%
    4. Thermo Fisher Scientific Inc — 4.33%
    5. Unitedhealth Group Inc — 3.49%
    6. Alnylam Pharmaceuticals Inc — 2.40%
    7. Gilead Sciences Inc — 2.21%
    8. Boston Scientific Corp — 2.17%
    9. Ascendis Pharma A/s — 2.17%
    10. Fidelity Revere Street Trust — 2.17%

    FAQ

    What is the difference between GNMX and FSPHX?
    GNMX (Corgi Genomics & Precision Medicine ETF) and FSPHX (Health Care Portfolio) are both etfs.
    Should I own both GNMX and FSPHX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.